...
首页> 外文期刊>Cancer biology & therapy >Fruquintinib effectively controlled the advanced small bowel adenocarcinoma progressed after multiple lines of palliative treatment: a case report and literature review
【24h】

Fruquintinib effectively controlled the advanced small bowel adenocarcinoma progressed after multiple lines of palliative treatment: a case report and literature review

机译:Fruquintinib有效地控制了先进的小肠腺癌在多行姑息治疗后进展:案例报告和文献综述

获取原文
获取原文并翻译 | 示例
           

摘要

Small bowel cancer is a very rare disease. It can be treated by surgery at early stages; however, there is no standard therapeutic strategy established for the treatment of unresectable and/or metastatic diseases.
机译:None

著录项

  • 来源
    《Cancer biology & therapy》 |2020年第12期|共4页
  • 作者单位

    Zhejiang Univ Key Lab Canc Prevent &

    Intervent Affiliated Hosp 2 Dept Med Oncol Minist Educ Sch;

    Zhejiang Univ Key Lab Canc Prevent &

    Intervent Affiliated Hosp 2 Dept Med Oncol Minist Educ Sch;

    Zhejiang Univ Key Lab Canc Prevent &

    Intervent Affiliated Hosp 2 Dept Med Oncol Minist Educ Sch;

    Zhejiang Univ Affiliated Hosp 2 Dept Colorectal Surg Sch Med Hangzhou Peoples R China;

    Zhejiang Univ Affiliated Hosp 2 Dept Colorectal Surg Sch Med Hangzhou Peoples R China;

    Zhejiang Univ Key Lab Canc Prevent &

    Intervent Affiliated Hosp 2 Dept Med Oncol Minist Educ Sch;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Fruquintinib; Small bowel adenocarcinoma; HER-2 amplification; Cetuximab; Palliative treatment;

    机译:Fruquintinib;小肠腺癌;Her-2扩增;西妥昔单抗;姑息治疗;

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号